Abstract
A specificity protein 1 (Sp1) zinc finger domain containing two tandem zinc fingers was fused to the C terminus of the integrase (IN) protein of the Moloney murine leukemia virus (MuLV). The integrity of the MuLV IN was completely preserved, since the fusion was conducted at the last amino acid residue of the protein. The vector pMIN-Sp1, which carried the fused MuLV IN-Sp1 zinc finger domain gene, was cotransfected with a wild-type MuLV vector pMLV-K to NIH/3T3 cells. A nonradioactive reverse transcriptase assay was performed on culture supernatants collected from the cotransfected cells to confirm the production of recombinant viruses. The expression of the fusion protein and the integration of the MuLV genome by the fusion protein were confirmed by a Northern and then a Southern hybridization analysis on the total RNA or genomic DNA extracted from cells infected by viruses collected from the supernatants of the cotransfected cells. Regions of the host chromosome that were selected by the fusion protein as the integration targets were sequenced using the TOPO™ cloning method on a series of PCR products generated with a nested set of primers. The percentage of positive clones screened that contained the DNA-binding sequence of the fused Sp1 zinc finger domain was around 13% (5 out of 39 clones). It was found that the Sp1 DNA-binding sequence was only present in regions that were proximal to one of the long terminal repeats of the integrated viral genome, suggesting that the fusion protein could select a target sequence for integration. The host flanking sequences determined for all the positive clones were also used as queries to perform a BLAST search on the GenBank mouse EST entries. Although matching scores for sequences of some of the clones computed were more significant than others, it was difficult to judge whether or not the integration in these clones had been targeted to some gene sequences. Most of the integration sites might exist in the introns, since we found that the probability of the gene sequences containing an Sp1 DNA-binding site was low.
Similar content being viewed by others
References
Altschul SF, Madden TL, Shaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389–3402;1997.
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds): Current Protocols in Molecular Biology. New York, Wiley, 1998, vol 1, pp 4.0.1–4.9.12.
Bor YC, Bushman F, Orgel L. In vitro integration of human immunodeficiency virus type 1 cDNA into targets containing protein-induced bends. Proc Natl Acad Sci USA 92:10334–10338;1995.
Bushman FD. Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc Natl Acad Sci USA 91:9233–9237;1994.
Bushman FD, Craigie R. Integration of human immunodeficiency virus DNA: Adduct interference analysis of required DNA sites. Proc Natl Acad Sci USA 89:3458–3462;1992.
Bushman FD, Miller MD. Tethering human immunodeficiency virus type 1 preintegration complexes to target DNA promotes integration at nearby sites. J Virol 71:458–464;1997.
Dotan I, Scottoline BP, Heuer TS, Brown PO. Characterization of recombinant murine leukemia virus integrase. J Virol 69:456–468;1995.
Engelman A, Hickman AB, Craigie R. The core and carboxy-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J Virol 68:5911–5917;1994.
Foulkes NS, Melstrom B, Benusiglio E, Sassone-Corsi P. Developmental switch of CREM function during spermatogenesis: From antagonist to activator. Nature 355:80–84;1992.
Gill G, Pascal E, Tseng ZH, Tjian R. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of theDrosophila TFII D complex and mediates transcriptional activation. Proc Natl Acad Sci USA 91:192–196;1994.
Goff SP. Genetics of retroviral integration. Annu Rev Genet 26:527–544;1992.
Goulaouic H, Chow SA. Direct integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase andEscherichia coli LexA protein. J Virol 70:37–46;1996.
Hartung S, Jaenisch R, Breindl M. Retrovirus insertion inactivates mouse α1(I) collagen gene by blocking initiation of transcription. Nature 320:365–367;1986.
Hodny Z, Li R, Barath P, Nelson BD. Sp1 and chromatin environment are important contributors to the formation of repressive chromatin structures on the transfected human adenine nucleotide translocase-2 promoter. Biochem J 346:93–97;2000.
Hoey T, Weinzierl ROJ, Gil G, Chen JL, Dynlacht BD, Tjian R. Molecular cloning and functional analysis ofDrosophila TAF110 reveal properties expected of coactivators. Cell 72:247–260;1993.
Hollenberg SM, Evans RM. Multiple and co-operative trans-activation domains of the human glucocorticoid receptor. Cell 55:899–906;1988.
Johnson MS, McClure MA, Feng DF, Gray J, Doolittle RF. Computer analysis of retroviral pol genes: Assignment of enzymatic functions to specific sequences and homologies with non-viral enzymes. Proc Natl Acad Sci USA 83:7648–7652;1986.
Jonsson CB, Donzella GA, Gaucan E, Smith CM, Roth MJ. Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysis. J Virol 70:4585–4597;1996.
Jonsson CB, Donzella GA, Roth MJ. Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified fromEscherichia coli. J Biol Chem 268:1462–1469;1993.
Jonsson CB, Roth MJ. Role of the His-Cys finger of Moloney murine leukemia virus integrase protein in integration and disintegration. J Virol 67:5562–5571;1993.
Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP. Binding and stimulation of HIV-1 integrase by a human homology of yeast transcription factor SNF5. Science 266:2002–2006;1994.
Katz RA, Merkel G, Skalka AM. Targeting of retroviral integraae by fusion to a heterologous DNA binding domain: In vitro activities and incorporation of a fusion protein into viral particles. Virology 217:178–190;1996.
Katz RA, Skalka AM. The retroviral enzymes. Annu Rev Biochem 63:133–173;1994.
Khan E, Mack JPG, Katz RA, Kulkosky J, Skalka AM. Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res 19:851–860;1991.
Kirchner J, Connolly CM, Sandmeyer SB. Requirement of RNA polymerase III transcription factors for in vitro position-specific integration of a retrovirus like element. Science 267:1488–1491;1995.
Kulkosky J, Skalka AM. Molecular mechanism of retroviral DNA integration. Pharmacol Ther 61:185–203;1994.
Lee JS, Galvin KM, Shi Y. Evidence for physical interaction between the zinc-finger transcription factor YY1 and Sp1. Proc Natl Acad Sci USA 90:6145–6149;1993.
Li B, Adams CC, Workman JL. Nucleosome binding by the constitutive transcription factor Sp1. J Biol Chem 269:7756–7763;1994.
Li XL, Lei XD, Cai H, Li J, Yang SL, Wang CC, Tsou CL. Binding of a burst-phase intermediate formed in the folding of denatured D-glyceraldehyde-3-phosphate dehydrogenase by chaperonin 60 and 8-anilino-1-naphthalenesulphonic acid. Biochem J 331:505–511;1998.
Miller AD, Verma IM. Two base changes restore infectivity to a noninfectious molecular clone of Moloney murine leukemia virus pMLV-1. J Virol 49:214–222;1984.
Minamitoni T, Ariga H, Matsumoto K. Transcription factor Sp1 activates the expression of the mouse tenascin-X gene. Biochem Biophys Res Commun 267:626–631;2000.
Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245:371–378;1989.
Muller HP, Varmus HE. DNA bending creates favored sites for retroviral integration: An explanation for preferred insertion sites in nucleosomes. EMBO J 13:4704–4714;1994.
Mumm SR, Grandgenett DP. Defining nucleic acid-binding properties of avian retrovirus integrase by deletion analysis. J Virol 65:1160–1167;1991.
Pascal E, Tjian R. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev 5:1646–1656;1991.
Persengiev SP, Saffer JD, Kilpatrick DL. An alternatively spliced form of the transcription factor Sp1 containing only a single glutamine-rich transactivation domain. Proc Natl Acad Sci USA 92:9107–9111;1995.
Pruss D, Bushman FD, Wolffe AP. Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc Natl Acad Sci USA 91:5913–5917;1994.
Pruss D, Reeves R, Bushman FD, Wolffe AP. The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J Biol Chem 269:25031–25041;1994.
Pryciak PM, Muller HP, Varmus HE. Simian virus 40 minichromosomes as targets for retroviral integration in vivo. Proc Natl Acad Sci USA 89:9237–9241;1992.
Pryciak PM, Varmus HE. Nucleosomes, DNA binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69:769–780;1992.
Ryu S, Zhou S, Ladurner AG, Tjian R. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature 397:446–450;1999.
Schauer M, Billich A. The N-terminal region of HIV-1 integrase is required for integration activity, but not for DNA-binding. Biochem Biophys Res Commun 185:874–880;1992.
Scherdin U, Rhodes K, Breindl M. Transcriptionally active genome regions are preferred targets for retrovirus integration. J Virol 64:907–912;1990.
Schubeler D, Maass K, Bode J. Retargeting of retroviral integration sites for the predictable expression of transgenes and the analysis of cis-acting sequences. Biochemistry 37:11907–11914;1998.
Scottoline BP, Chow S, Ellison V, Brown PO. Disruption of the terminal base pairs of retroviral DNA during integration. Genes Dev 11:371–382;1997.
Stone EM, Rothblum KN, Alevy MC, Kuo TM, Schwartz RJ. Complete sequence of the chicken glyceraldehyde-3-phosphate dehydrogenase gene. Proc Natl Acad Sci USA 82:628–635;1985.
Theill LE, Castrillo JL, Wu D, Karin M. Dissection of functional domains of the pituitary-specific transcription factor GHF-1. Nature 342:945–948;1989.
Vidali G, Boffa LC, Bradbury EM, Allfrey VG. Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased Dnase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci USA 75:2239–2243;1978.
Vink C, Oude Groeneger AAM, Plasterk RHA. Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type 1 integrase protein. Nucleic Acids Res 21:1419–1425;1993.
Wei SQ, Mizzuchi K, Craigie R. Footprints on the viral DNA ends in Moloney murine leukemia virus preintegration complexes reflect a specific association with integrase. Proc Natl Acad Sci USA 95:10535–10540;1998.
Woerner AM, Klutch M, Levin JG, Markus-Sekura CJ. Localization of DNA binding activity of HIV-1 integrase to the C-terminal half of the protein. AIDS Res Hum Retroviruses 8:297–304;1992.
Woerner AM, Markus-Sekura CJ. Characterization of a DNA binding domain in the C-terminus of HIV-1 integrase by deletion mutagenesis. Nucleic Acids Res 21:3507–3511;1993.
Zheng R, Jenkins TM, Craigie R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc Natl Acad Sci USA 93:13659–13664;1996.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peng, WJ., Chang, CM. & Lin, TH. Target integration by a chimeric Sp1 zinc finger domain-moloney murine leukemia virus integrase in vivo. J Biomed Sci 9, 171–184 (2002). https://doi.org/10.1007/BF02256029
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02256029